These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 37063459)

  • 41. Clinical and translational potential of MRI evaluation in knee osteoarthritis.
    Hayashi D; Guermazi A; Kwoh CK
    Curr Rheumatol Rep; 2014 Jan; 16(1):391. PubMed ID: 24318386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets.
    Le Graverand-Gastineau MP
    Curr Drug Targets; 2010 May; 11(5):528-35. PubMed ID: 20199396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prospects for Therapies in Osteoarthritis.
    Ghouri A; Conaghan PG
    Calcif Tissue Int; 2021 Sep; 109(3):339-350. PubMed ID: 32055890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overcoming barriers for intra-articular delivery of disease-modifying osteoarthritis drugs.
    Gao J; Xia Z; Mary HB; Joseph J; Luo JN; Joshi N
    Trends Pharmacol Sci; 2022 Mar; 43(3):171-187. PubMed ID: 35086691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The current state of the osteoarthritis drug development pipeline: a comprehensive narrative review of the present challenges and future opportunities.
    Kim H; Seo J; Lee Y; Park K; Perry TA; Arden NK; Mobasheri A; Choi H
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221085952. PubMed ID: 36504595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Location-independent analysis of structural progression of osteoarthritis-Taking it all apart, and putting the puzzle back together makes the difference.
    Eckstein F; Buck R; Wirth W
    Semin Arthritis Rheum; 2017 Feb; 46(4):404-410. PubMed ID: 27717491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What is new in pharmacological treatment for osteoarthritis?
    Gezer HH; Ostor A
    Best Pract Res Clin Rheumatol; 2023 Jun; 37(2):101841. PubMed ID: 37302928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Considerations when designing a disease-modifying osteoarthritis drug (DMOAD) trial using radiography.
    Hellio Le Graverand MP; Clemmer RS; Brunell RM; Hayes CW; Miller CG; Vignon E
    Semin Arthritis Rheum; 2013 Aug; 43(1):1-8. PubMed ID: 23290692
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imaging in osteoarthritis: what have we learned and where are we going?
    Hayashi D; Guermazi A; Crema MD; Roemer FW
    Minerva Med; 2011 Feb; 102(1):15-32. PubMed ID: 21317846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. KARAOKE: Krill oil versus placebo in the treatment of knee osteoarthritis: protocol for a randomised controlled trial.
    Laslett LL; Antony B; Wluka AE; Hill C; March L; Keen HI; Otahal P; Cicuttini FM; Jones G
    Trials; 2020 Jan; 21(1):79. PubMed ID: 31937352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 18F-NaF simultaneous PET/MRI in osteoarthritis: Initial observations with case illustration.
    Jena A; Goyal N; Vaishya R
    J Clin Orthop Trauma; 2021 Nov; 22():101569. PubMed ID: 34513587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL4-10 Fusion Protein Shows DMOAD Activity in a Rat Osteoarthritis Model.
    van Helvoort EM; de Visser HM; Lafeber FPJG; Coeleveld K; Versteeg S; Weinans HH; Popov-Celeketic J; Eijkelkamp N; Mastbergen SC
    Cartilage; 2021 Dec; 13(2_suppl):1155S-1164S. PubMed ID: 34159843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Latest advancements in imaging techniques in OA.
    Hayashi D; Roemer FW; Link T; Li X; Kogan F; Segal NA; Omoumi P; Guermazi A
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X221146621. PubMed ID: 36601087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Candidates for Intra-Articular Administration Therapeutics and Therapies of Osteoarthritis.
    Toyoda E; Maehara M; Watanabe M; Sato M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. OARSI/OMERACT criteria of being considered a candidate for total joint replacement in knee/hip osteoarthritis as an endpoint in clinical trials evaluating potential disease modifying osteoarthritic drugs.
    Dougados M; Hawker G; Lohmander S; Davis AM; Dieppe P; Maillefert JF; Gossec L
    J Rheumatol; 2009 Sep; 36(9):2097-9. PubMed ID: 19738220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MR-Imaging in Osteoarthritis: Current Standard of Practice and Future Outlook.
    Ehmig J; Engel G; Lotz J; Lehmann W; Taheri S; Schilling AF; Seif Amir Hosseini A; Panahi B
    Diagnostics (Basel); 2023 Aug; 13(15):. PubMed ID: 37568949
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel disease-modifying osteoarthritis drug candidate targeting Runx1.
    Yano F; Hojo H; Ohba S; Fukai A; Hosaka Y; Ikeda T; Saito T; Hirata M; Chikuda H; Takato T; Kawaguchi H; Chung UI
    Ann Rheum Dis; 2013 May; 72(5):748-53. PubMed ID: 23041841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on novel pharmacological therapies for osteoarthritis.
    Ghouri A; Conaghan PG
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19864492. PubMed ID: 31384314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?
    Losina E; Burbine SA; Suter LG; Hunter DJ; Solomon DH; Daigle ME; Dervan EE; Jordan JM; Katz JN
    Osteoarthritis Cartilage; 2014 Mar; 22(3):415-30. PubMed ID: 24487044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.